Lifecycle Convergence Fund

From discovery
to exit,
every stage.

Stratsphere backs transformative companies across MedTech, Biotech, DeepTech, and Sustainability — from the first thesis to the final close.

$240M

Capital deployed

Portfolio companies

90%

Biotech / MedTech exits

3–10×

MOIC range

Investment thesis

Where we
back conviction

Diagnostics, surgical robotics, digital health, medical devices, and clinical-stage biotools.

Drug discovery platforms, genomics, proteomics, synthetic biology, and precision medicine.

AI/ML infrastructure, quantum computing, advanced materials, and frontier R&D.

Clean energy, carbon capture, circular economy platforms, and climate-aligned infrastructure.

Get involved

Apply for funding

Founders building in our four focus sectors.

LP access

Accredited investors and institutional LPs.

"We back scientists who become operators,
operators who become founders,
and founders who become category leaders."

General Partners, Stratsphere LLC